According to the research report titled ‘Global Neurovascular device market size study, by Device (cerebral, embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices), by Application (stroke, cerebral artery stenosis, cerebral aneurysm, others) and regional forecasts 2021-2027’, available with Market Study Report, global neurovascular device market was assessed at USD 2.7 billion in 2020 and is anticipated to be worth USD 4.01 billion by 2027, expanding at 5.8% CAGR between 2021-2027.
 

Surging population, adoption of advanced technologies in neurointerventional sector, and growing number of patients are key factors driving global neurovascular device market expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3839623/
 

For the unversed, neurovascular devices are primarily used to treat disorders in which a part of the brain is permanently or temporarily affected by bleeding or restricted blood flow such as aneurysm. These devices include coils, clips, and stents.
 

Rising investments in healthcare infrastructure will aid industry growth over the analysis timeframe. According to the IBEF, the healthcare budget of India for 2021 was assessed at USD 30.70 billion. Meanwhile, as per the NHS budget, in 2020-2021, planned spending for the Department of Health and Social Care in England was evaluated at USD 212.1 billion.
 

While growing demand for minimally invasive procedures will facilitate market proliferation, high cost of neurovascular devices is poised to act as a challenge. 
 

Based on devices, the industry is divided into cerebral, neurothrombectomy devices, embolization & aneurysm coiling devices, cerebral angioplasty & stenting systems, and support devices. Speaking of application scope, the market sphere is bifurcated into stroke, cerebral aneurysm, cerebral artery stenosis, and others.
 

Regionally speaking, Europe held majority of worldwide neurovascular device industry share in the past year due to well developed healthcare infrastructure and promptness & affordability of urgent care services. Meanwhile, Asia Pacific market is projected to record significant expansion between 2021-2027, owing to growing incidences of injuries, increasing disposable income, and enhancements in healthcare infrastructure.
 

Key players shaping global neurovascular device market trends are Medtronic plc, MicroVention Inc. (Terumo Corporation), MicroPort Scientific Corporation, Johnson & Johnson Services Inc., Codman Neuro (Integra LifeSciences Corporation), Stryker Corporation, Abbott Laboratories, Penumbra Inc., Merit Medical Systems Inc., and W.L. Gore & Associates Inc.